Pathogenesis of chronic hyperglycemia: From reductive stress to oxidative stress

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Yan, Liang Jun ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXOSAMINE; POLYOL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE; ALPHA-GLYCEROPHOSPHORIC ACID; GLYCEROPHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

AUTOOXIDATION; BIOACCUMULATION; CELL STRESS; CHRONIC DISEASE; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; GLYCATION; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; MITOCHONDRIAL RESPIRATION; OXIDATIVE STRESS; PATHOGENESIS; RECYCLING; REDUCTIVE STRESS; RESPIRATORY CHAIN; REVIEW; ELECTRON TRANSPORT; METABOLIC SYNDROME X; METABOLISM; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY;

DIABETES MELLITUS, TYPE 2; ELECTRON TRANSPORT; GLUCOSE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GLYCEROPHOSPHATES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; METABOLIC SYNDROME X; MITOCHONDRIA; NAD; OXIDATIVE STRESS; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 84904192156     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/137919     Document Type: Review

References (191)

1. Prentki M., Nolan C. J., Islet β cell failure in type 2 diabetes. Journal of Clinical Investigation 2006 116 7 1802 1812 2-s2.0-33745863033 10.1172/JCI29103 (Pubitemid 44033300)
2. Gupta D., Krueger C. B., Lastra G., Over-nutrition, obesity and insulin resistance in the development of β -cell dysfunction. Current Diabetes Reviews 2012 8 2 76 83 2-s2.0-84857730813 10.2174/157339912799424564
3. Cai D., Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends in Endocrinology and Metabolism 2013 24 1 40 47 2-s2.0-84871650203 10.1016/j.tem.2012.11.003
4. DeFronzo R. A., Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Netherlands Journal of Medicine 1997 50 5 191 197 2-s2.0-0030938616 10.1016/S0300-2977(97) 00012-0 (Pubitemid 27240251)
5. Tuch B., Dunlop M., Proietto J., Diabetes Research: A Guide for Postgraduates 2000 Harwood Academic Publishers
6. Barnett A. H., Type 2 Diabetes 2012 2nd Oxford University Press
7. DeFronzo R. A., Pathogenesis of type 2 diabetes mellitus. Medical Clinics of North America 2004 88 4 787 835 2-s2.0-4143151942 10.1016/j.mcna.2004.04.013 (Pubitemid 39090340)
8. Kahn S. E., Cooper M. E., Del Prato S., Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. The Lancet 2014 383 1068 1083
9. Szkudelski T., Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Experimental Biology and Medicine 2012 237 5 481 490 2-s2.0-84862006013 10.1258/ebm.2012.011372
10. Heagerty A. M., Aalkjaer C., Bund S. J., Korsgaard N., Mulvany M. J., Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension 1993 21 4 391 397 2-s2.0-0027511750 (Pubitemid 23095149)
11. Forbes J. M., Cooper M. E., Mechanisms of diabetic complications. Physiological Reviews 2013 93 1 137 188 2-s2.0-84872313601 10.1152/physrev. 00045.2011
12. Stirban A., Gawlowski T., Roden M., Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Molecular Metabolism 2013 3 94 108
13. Leibowitz G., Bachar E., Shaked M., Sinai A., Ketzinel-Gilad M., Cerasi E., Kaiser N., Glucose regulation of β -cell stress in type 2 diabetes. Diabetes, Obesity and Metabolism 2010 12 2 66 75 2-s2.0-77957318944 10.1111/j.1463-1326.2010.01280.x
14. Somesh B. P., Verma M. K., Sadasivuni M. K., Mammen-Oommen A., Biswas S., Shilpa P. C., Reddy A. K., Yateesh A. N., Pallavi P. M., Nethra S., Smitha R., Neelima K., Narayanan U., Jagannath M. R., Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity. BMC Cell Biology 2013 14 1, article 31 2-s2.0-84879495791 10.1186/1471-2121-14-31
15. Dedoussis G. V. Z., Kaliora A. C., Panagiotakos D. B., Genes, diet and type 2 diabetes mellitus: a review. Review of Diabetic Studies 2007 4 1 13 24 2-s2.0-34548857902 10.1900/RDS.2007.3.13 (Pubitemid 47450221)
16. Del Prato S., Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabetic Medicine 2009 26 12 1185 1192 2-s2.0-70549113397 10.1111/j.1464-5491. 2009.02847.x
17. Bensellam M., Laybutt D. R., Jonas J.-C., The molecular mechanisms of pancreatic β -cell glucotoxicity: recent findings and future research directions. Molecular and Cellular Endocrinology 2012 364 1-2 1 27 2-s2.0-84867507940 10.1016/j.mce.2012.08.003
18. Rösen P., Nawroth P. P., King G., Möller W., Tritschler H.-J., Packer L., The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American diabetes association and the German diabetes society. Diabetes/Metabolism Research and Reviews 2001 17 3 189 212 2-s2.0-0034939115 10.1002/dmrr.196 (Pubitemid 32624602)
19. Bandeira S. D. M., da Fonseca L. J. S., Guedes G. D. S., Rabelo L. A., Goulart M. O. F., Vasconcelos S. M. L., Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. International Journal of Molecular Sciences 2013 14 2 3265 3284 2-s2.0-84875120227 10.3390/ijms14023265
20. Stadler K., Oxidative stress in diabetes. Advances in Experimental Medicine and Biology 2012 771 272 287 2-s2.0-84874529414
21. Robertson A. P., Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. Journal of Biological Chemistry 2004 279 41 42351 42354 2-s2.0-5644248079 10.1074/jbc.R400019200 (Pubitemid 39372114)
22. Giacco F., Brownlee M., Oxidative stress and diabetic complications. Circulation Research 2010 107 9 1058 1070 2-s2.0-78349297565 10.1161/CIRCRESAHA.110.223545
23. Arora M. K., Singh U. K., Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy. Current Drug Targets 2014 15 531 538
24. Fiorentino T. V., Prioletta A., Zuo P., Folli F., Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Current Pharmaceutical Design 2013 19 5695 5703
25. Mortuza R., Chakrabarti S., Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy. Heart Failure Reviews 2014 19 1 75 86 2-s2.0-84873980047 10.1007/s10741-013-9381-z
26. Ruderman N. B., Carling D., Prentki M., Cacicedo J. M., AMPK, insulin resistance, and the metabolic syndrome. Journal of Clinical Investigation 2013 123 7 2764 2772 2-s2.0-84879621442 10.1172/JCI67227
27. Williamson J. R., Ido Y., Understanding retinal cytosolic reductive stress. Investigative Ophthalmology & Visual Science 1998 39 7 1295 1296 2-s2.0-0032085366
28. Williamson J. R., Kilo C., Ido Y., The role of cytosolic reductive stress in oxidant formation and diabetic complications. Diabetes Research and Clinical Practice 1999 45 2-3 81 82 2-s2.0-0032874392 10.1016/S0168-8227(99)00034-0 (Pubitemid 29457753)
29. Ido Y., Williamson J. R., Hyperglycemic cytosolic reductive stress "pseudohypoxia": implications for diabetic retinopathy. Investigative Ophthalmology & Visual Science 1997 38 8 1467 1470 2-s2.0-0031181410
30. Ghyczy M., Boros M., Electrophilic methyl groups present in the diet ameliorate pathological states induced by reductive and oxidative stress: a hypothesis. British Journal of Nutrition 2001 85 4 409 414 2-s2.0-0035036447 (Pubitemid 32435534)
31. Teodoro J. S., Rolo A. P., Palmeira C. M., The NAD ratio redox paradox: why does too much reductive power cause oxidative stress? Toxicology Mechanisms and Methods 2013 23 5 297 302 2-s2.0-84878533789 10.3109/15376516.2012.759305
32. Tilton R. G., Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. Microscopy Research and Technique 2002 57 5 390 407 2-s2.0-0036605475 10.1002/jemt.10092 (Pubitemid 34579219)
33. Bassi R., Trevisani A., Tezza S., Ben Nasr M., Gatti F., Vergani A., Farina A., Fiorina P., Regenerative therapies for diabetic microangiopathy. Experimental Diabetes Research 2012 2012 11 2-s2.0-84859772510 10.1155/2012/916560 916560
34. Klover P. J., Mooney R. A., Hepatocytes: critical for glucose homeostasis. International Journal of Biochemistry and Cell Biology 2004 36 5 753 758 2-s2.0-1542285160 10.1016/j.biocel.2003.10.002 (Pubitemid 38299389)
35. Gerich J. E., Woerle H. J., Meyer C., Stumvoll M., Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 2001 24 2 382 391 2-s2.0-0035146344 (Pubitemid 32119142)
36. Gerich J. E., Control of glycaemia. Bailliere's Clinical Endocrinology and Metabolism 1993 7 3 551 586 2-s2.0-0027217790 (Pubitemid 23243426)
37. DeFronzo R. A., Ferrannini E., Regulation of hepatic glucose metabolism in humans. Diabetes/Metabolism Reviews 1987 3 2 415 459 2-s2.0-0023090430 (Pubitemid 17050765)
38. Valadi H., Valadi Å., Ansell R., Gustafsson L., Adler L., Norbeck J., Blomberg A., NADH-reductive stress in Saccharomyces cerevisiae induces the expression of the minor isoform of glyceraldehyde-3-phosphate dehydrogenase (TDH1). Current Genetics 2004 45 2 90 95 2-s2.0-1442350535 10.1007/s00294-003- 0469-1 (Pubitemid 38292230)
39. Farhana A., Guidry L., Srivastava A., Singh A., Hondalus M. K., Steyn A. J. C., Reductive stress in microbes: implications for understanding mycobacterium tuberculosis disease and persistence. Advances in Microbial Physiology 2010 57 43 117 2-s2.0-78349251639 10.1016/B978-0-12-381045-8.00002-3
40. Lipinski B., Ghyczy M., Boros M., Evidence in support of a concept of reductive stress (multiple letters). British Journal of Nutrition 2002 87 1 93 94 2-s2.0-0036160119 (Pubitemid 34116446)
41. Gomes A. P., Price N. L., Ling A. J., Moslehi J. J., Montgomery M. K., Rajman L., White J. P., Teodoro J. S., Wrann C. D., Hubbard B. P., Mercken E. M., Palmeira C. M., de Cabo R., Rolo A. P., Turner N., Bell E. L., Sinclair D. A., Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 2013 155 1624 1638
42. Obrosova I. G., Stevens M. J., Lang H.-J., Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy. Pharmacology 2001 62 3 172 180 2-s2.0-0035095478 10.1159/000056091 (Pubitemid 32260858)
43. Van den Enden M. K., Nyengaard J. R., Ostrow E., Burgan J. H., Williamson J. R., Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism: implications for diabetic retinopathy. Investigative Ophthalmology and Visual Science 1995 36 8 1675 1685 2-s2.0-0029032001
44. Williamson J. R., Chang K., Frangos M., Hasan K. S., Ido Y., Kawamura T., Nyengaard J. R., Van den Enden M., Kilo C., Tilton R. G., Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993 42 6 801 813 2-s2.0-0027318772 (Pubitemid 23151571)
45. Karunanayake E. H., Hearse D. J., Mellows G., The synthesis of [14C]streptozotocin and its distribution and excretion in the rat. Biochemical Journal 1974 142 3 673 683 2-s2.0-0016135844
46. Virág L., Szabó C., The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacological Reviews 2002 54 3 375 429 2-s2.0-0036733355 10.1124/pr.54.3.375
47. Chiu J., Xu B. Y., Chen S., Feng B., Chakrabarti S., Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. Canadian Journal of Physiology and Pharmacology 2008 86 6 365 372 2-s2.0-44949152594 10.1139/Y08-033 (Pubitemid 351821130)
48. Oka S.-I., Hsu C.-P., Sadoshima J., Regulation of cell survival and death by pyridine nucleotides. Circulation Research 2012 111 5 611 627 2-s2.0-84865525580 10.1161/CIRCRESAHA.111.247932
49. Bánhegyi G., Mandl J., Csala M., Redox-based endoplasmic reticulum dysfunction in neurological diseases. Journal of Neurochemistry 2008 107 1 20 34 2-s2.0-51849162371 10.1111/j.1471-4159.2008.05571.x
50. Rajasekaran N. S., Connell P., Christians E. S., Yan L.-J., Taylor R. P., Orosz A., Zhang X. Q., Stevenson T. J., Peshock R. M., Leopold J. A., Barry W. H., Loscalzo J., Odelberg S. J., Benjamin I. J., Human B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 2007 130 3 427 439 2-s2.0-34547681313 10.1016/j.cell.2007.06.044 (Pubitemid 47208522)
51. Yu Q., Lee C. F., Wang W., Karamanlidis G., Kuroda J., Matsushima S., Sadoshima J., Tian R., Elimination of NADPH oxidase activity promotes reductive stress and sensitizes the heart to ischemic injury. Journal of the American Heart Association 2014 3 e000555
52. Jones D. P., Go Y.-M., Redox compartmentalization and cellular stress. Diabetes, Obesity and Metabolism 2010 12 2 116 125 2-s2.0-77957315403 10.1111/j.1463-1326.2010.01266.x
53. Lugrin J., Rosenblatt-Velin N., Parapanov R., Liaudet L., The role of oxidative stress during inflammatory processes. Biological Chemistry 2014 395 203 230
54. Naviaux R. K., Oxidative shielding or oxidative stress? Journal of Pharmacology and Experimental Therapeutics 2012 342 3 608 618 2-s2.0-84865182100 10.1124/jpet.112.192120
55. He Q., Wang M., Petucci C., Gardell S. J., Han X., Rotenone induces reductive stress and triacylglycerol deposition in C2C12 cells. International Journal of Biochemistry and Cell Biology 2013 45 2749 2755
56. Esposti M. D., Ngo A., Myers M. A., Inhibition of mitochondrial complex I may account for IDDM induced by intoxication with the rodenticide vacor. Diabetes 1996 45 11 1531 1534 2-s2.0-0029909113 (Pubitemid 26357545)
57. Lamson D. W., Plaza S. M., Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment. Alternative Medicine Review 2002 7 2 94 111 2-s2.0-0036241245 (Pubitemid 34461522)
58. Abdul-Ghani M. A., DeFronzo R. A., Pathogenesis of insulin resistance in skeletal muscle. Journal of Biomedicine and Biotechnology 2010 2010 19 10.1155/2010/476279 476279
59. Wamelink M. M. C., Struys E. A., Jakobs C., The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. Journal of Inherited Metabolic Disease 2008 31 6 703 717 2-s2.0-57649178844 10.1007/s10545-008-1015-6
60. Ola M. S., Berkich D. A., Xu Y., King M. T., Gardner T. W., Simpson I., LaNoue K. F., Analysis of glucose metabolism in diabetic rat retinas. The American Journal of Physiology: Endocrinology and Metabolism 2006 290 6 E1057 E1067 2-s2.0-33744945512 10.1152/ajpendo.00323.2005 (Pubitemid 43847888)
61. Rosca M. G., Vazquez E. J., Chen Q., Kerner J., Kern T. S., Hoppel C. L., Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes 2012 61 8 2074 2083 2-s2.0-84864387242 10.2337/db11-1437
62. Rebolledo O. R., Actis Dato S. M., Postprandial hyperglycemia and hyperlipidemia-generated glycoxidative stress: its contribution to the pathogenesis of diabetes complications. European Review for Medical and Pharmacological Sciences 2005 9 4 191 208 2-s2.0-23744481257 (Pubitemid 41136435)
63. Reyes A., Cardenas M. L., All hexokinase isoenzymes coexist in rat hepatocytes. Biochemical Journal 1984 221 2 303 309 2-s2.0-0021216982 (Pubitemid 14052326)
64. Otaegui P. J., Ferre T., Pujol A., Riu E., Jimenez R., Bosch F., Expression of glucokinase in skeletal muscle: a new approach to counteract diabetic hyperglycemia. Human Gene Therapy 2000 11 11 1543 1552 2-s2.0-0034691510 10.1089/10430340050083270 (Pubitemid 30670606)
65. Pal M., Recent advances in glucokinase activators for the treatment of type 2 diabetes. Drug Discovery Today 2009 14 15-16 784 792 2-s2.0-67651213750 10.1016/j.drudis.2009.05.013
66. Matschinsky F. M., Regulation of pancreatic β -cell glucokinase: from basics to therapeutics. Diabetes 2002 51 3 S394 S404 2-s2.0-0036896635 (Pubitemid 35403423)
67. Matschinsky F., Liang Y., Kesavan P., Wang L., Froguel P., Velho G., Cohen D., Alan Permutt M., Tanizawa Y., Jetton T. L., Niswender K., Magnuson M. A., Glucokinase as pancreatic β cell glucose sensor and diabetes gene. Journal of Clinical Investigation 1993 92 5 2092 2098 2-s2.0-0027358380 (Pubitemid 23333511)
68. Postic C., Shiota M., Magnuson M. A., Cell-specific roles of glucokinase in glucose homeostasis. Recent Progress in Hormone Research 2001 56 195 217 2-s2.0-0035787576 10.1210/rp.56.1.195 (Pubitemid 36068061)
69. Larion M., Miller B. G., Homotropic allosteric regulation in monomeric mammalian glucokinase. Archives of Biochemistry and Biophysics 2012 519 2 103 111 2-s2.0-84857803612 10.1016/j.abb.2011.11.007
70. Lenzen S., A fresh view of glycolysis and glucokinase regulation: history and current status. Journal of Biological Chemistry 2014 289 18 12189 12194 10.1074/jbc.R114.557314
71. Hirst J., King M. S., Pryde K. R., The production of reactive oxygen species by complex I. Biochemical Society Transactions 2008 36 5 976 980 2-s2.0-53849099653 10.1042/BST0360976
72. Pryde K. R., Hirst J., Superoxide is produced by the reduced flavin in mitochondrial complex I: a single, unified mechanism that applies during both forward and reverse electron transfer. Journal of Biological Chemistry 2011 286 20 18056 18065 2-s2.0-79955977892 10.1074/jbc.M110.186841
73. Hirst J., Mitochondrial complex I. Annual Review of Biochemistry 2013 82 551 575 2-s2.0-84878905186 10.1146/annurev-biochem-070511-103700
74. Kim J.-A., Wei Y., Sowers J. R., Role of mitochondrial dysfunction in insulin resistance. Circulation Research 2008 102 4 401 414 2-s2.0-41949114990 10.1161/CIRCRESAHA.107.165472 (Pubitemid 351651099)
75. Yan L. J., Protein redox modification as a cellular defense mechanism against tissue ischemic injury. Oxidative Medicine and Cellular Longevity 2014 2014 12 343154 10.1155/2014/343154
76. Esterházy D., King M. S., Yakovlev G., Hirst J., Production of reactive oxygen species by complex I (NADH:ubiquinone oxidoreductase) from Escherichia coli and comparison to the enzyme from mitochondria. Biochemistry 2008 47 12 3964 3971 2-s2.0-41149100550 10.1021/bi702243b (Pubitemid 351431385)
77. Ceriello A., Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005 54 1 1 7 2-s2.0-12144251636 10.2337/diabetes.54.1. 1 (Pubitemid 40105088)
78. St-Pierre J., Buckingham J. A., Roebuck S. J., Brand M. D., Topology of superoxide production from different sites in the mitochondrial electron transport chain. Journal of Biological Chemistry 2002 277 47 44784 44790 2-s2.0-0037160091 10.1074/jbc.M207217200 (Pubitemid 36159072)
79. Murphy M. P., How mitochondria produce reactive oxygen species. Biochemical Journal 2009 417 1 1 13 2-s2.0-58249093939 10.1042/BJ20081386
80. Dröse S., Brandt U., Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Advances in Experimental Medicine and Biology 2012 748 145 169 2-s2.0-84863738048 10.1007/978-1-4614-3573-0-6
81. Siebels I., Drose S., Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates. Biochimica et Biophysica Acta 2013 1827 1156 1164
82. Yan L.-J., Sumien N., Thangthaeng N., Forster M. J., Reversible inactivation of dihydrolipoamide dehydrogenase by mitochondrial hydrogen peroxide. Free Radical Research 2013 47 2 123 133 2-s2.0-84879303466 10.3109/10715762.2012.752078
83. Quinlan C. L., Goncalves R. L., Hey-Mogensen M., Yadava N., Bunik V. I., Brand M. D., The 2-oxoacid dehydrogenase complexes in mitochondria can produce superoxide/hydrogen peroxide at much higher rates than complex I. Journal of Biological Chemistry 2014 10.1074/jbc.M113.545301
84. Jackson M. J., Papa S., Bolaños J., Bruckdorfer R., Carlsen H., Elliott R. M., Flier J., Griffiths H. R., Heales S., Holst B., Lorusso M., Lund E., Øivind Moskaug J., Moser U., Di Paola M., Cristina Polidori M., Signorile A., Stahl W., Viña-Ribes J., Astley S. B., Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Molecular Aspects of Medicine 2002 23 1-3 209 285 2-s2.0-0036088349 10.1016/S0098-2997(02)00018-3 (Pubitemid 34678688)
85. Yan L. J., Positive oxidative stress in aging and aging-related disease tolerance. Redox Biology 2014 2 165 169
86. Turrens J. F., Alexandre A., Lehninger A. L., Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Archives of Biochemistry and Biophysics 1985 237 2 408 414 2-s2.0-0021996572 (Pubitemid 15144894)
87. Turrens J. F., Superoxide production by the mitochondrial respiratory chain. Bioscience Reports 1997 17 1 3 8 2-s2.0-0030969868 10.1023/A: 1027374931887 (Pubitemid 27267586)
88. Cai Z., Yan L. J., Protein oxidative modifications: beneficial roles in disease and health. Journal of Biochemical and Pharmacological Research 2013 1 15 26
89. Shah S., Iqbal M., Karam J., Salifu M., McFarlane S. I., Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights. Antioxidants and Redox Signaling 2007 9 7 911 929 2-s2.0-34250311296 10.1089/ars.2007.1629 (Pubitemid 46919593)
90. Yan L. J., Analysis of oxidative modification of proteins. Current Protocols in Protein Science 2009 chapter 14, unit 14 10.1002/0471140864. ps1404s55
91. Stadtman E. R., Biochemical markers of aging. Experimental Gerontology 1988 23 4-5 327 347 2-s2.0-0023682912
92. Yan L.-J., Levine R. L., Sohal R. S., Oxidative damage during aging targets mitochondrial aconitase. Proceedings of the National Academy of Sciences of the United States of America 1997 94 11168 11172 2-s2.0-0032539690 (Pubitemid 27450969)
93. Dawson T. L., Gores G. J., Nieminen A.-L., Herman B., Lemasters J. J., Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. The American Journal of Physiology: Cell Physiology 1993 264 4 C961 C967 2-s2.0-0027418625 (Pubitemid 23118118)
94. Pung Y. F., Chilian W. M., Corruption of coronary collateral growth in metabolic syndrome: role of oxidative stress. World Journal of Cardiology 2010 2 421 427
95. Pall M. L., Explaining "Unexplained Illnesses": Disease Paradigm for Chronic Fatigue Syndrome, Multiple Chemical Sensitivity, Fibromyalgia, Post-Traumatic Stress Disorder, and Gulf War Syndrome 2007 Harrington Park Press
96. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
97. Sakai K., Matsumoto K., Nishikawa T., Suefuji M., Nakamaru K., Hirashima Y., Kawashima J., Shirotani T., Ichinose K., Brownlee M., Araki E., Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β -cells. Biochemical and Biophysical Research Communications 2003 300 1 216 222 2-s2.0-0037228626 10.1016/S0006-291X(02)02832-2 (Pubitemid 36042955)
98. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengellér Z., Szabó C., Brownlee M., Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. Journal of Clinical Investigation 2003 112 7 1049 1057 2-s2.0-0242285699 10.1172/JCI200318127 (Pubitemid 38056320)
99. Zhang T., Gong Y., Zhou H., Xie P., Guan S., Yi W., Oxidative stress-the key mechanisms of diabetic peripheral neuropathy. North The American Journal of Medicine and Science 2013 6 87 90
100. Madsen-Bouterse S., Mohammad G., Kowluru R. A., Glyceraldehyde-3- phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy. Investigative Ophthalmology and Visual Science 2010 51 3 1765 1772 2-s2.0-77949879018 10.1167/iovs.09-4171
101. Fantus I. G., The pathogenesis of the chronic complications of the diabetes mellitus. Endocrinology Rounds 2002 2 1 8
102. Puthanveetil P., Zhang D., Wang Y., Wang F., Wan A., Abrahani A., Rodrigues B., Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1. Journal of Molecular and Cellular Cardiology 2012 53 5 677 686 2-s2.0-84867398874 10.1016/j.yjmcc.2012.08.013
103. Hwang N. R., Yim S.-H., Kim Y. M., Jeong J., Song E. J., Lee Y., Lee J. H., Choi S., Lee K.-J., Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions. Biochemical Journal 2009 423 2 253 264 2-s2.0-70350091586 10.1042/BJ20090854
104. Trentham D. R., Aspects of the chemistry of D-glyceraldehyde 3-phosphate dehydrogenase. Biochemical Journal 1968 109 4 603 612 2-s2.0-0014346621
105. Rivera-Nieves J., Thompson W. C., Levine R. L., Moss J., Thiols mediate superoxide-dependent NADH modification of glyceraldehyde-3-phosphate dehydrogenase. Journal of Biological Chemistry 1999 274 28 19525 19531 2-s2.0-0033538545 10.1074/jbc.274.28.19525 (Pubitemid 29327722)
106. Ussher J. R., Jaswal J. S., Lopaschuk G. D., Pyridine nucleotide regulation of cardiac intermediary metabolism. Circulation Research 2012 111 5 628 641 2-s2.0-84865462435 10.1161/CIRCRESAHA.111.246371
107. Funk S. D., Yurdagul A., Orr A. W., Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. International Journal of Vascular Medicine 2012 2012 19 2-s2.0-84866239730 10.1155/2012/569654 569654
108. Rask-Madsen C., King G. L., Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metabolism 2013 17 1 20 33 2-s2.0-84872158502 10.1016/j.cmet.2012.11.012
109. Abdul-Ghani M. A., DeFronzo R. A., Miwa S., Beckman K. B., Muller F. L., Oxidative stress in type 2 diabetes. Oxidative Stress in Aging 2008 Humana Press 191 212
110. Davidson M. B., Bate G., Kirkpatrick P., Fresh from the pipeline: exenatide. Nature Reviews Drug Discovery 2005 4 9 713 714 2-s2.0-26044462014 10.1038/nrd1828 (Pubitemid 43090485)
111. Poitout V., Robertson R. P., Minireview: secondary β -cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002 143 2 339 342 2-s2.0-0036153256 10.1210/en.143.2.339 (Pubitemid 34107184)
112. Poitout V., Robertson R. P., Glucolipotoxicity: fuel excess and β -cell dysfunction. Endocrine Reviews 2008 29 3 351 366 2-s2.0-43549108142 10.1210/er.2007-0023 (Pubitemid 351679704)
113. Yang Y., Hayden M. R., Sowers S., Bagree S. V., Sowers J. R., Retinal redox stress and remodeling in cardiometabolic syndrome and diabetes. Oxidative Medicine and Cellular Longevity 2010 3 6 2-s2.0-79951523106
114. Callaghan M. J., Ceradini D. J., Gurtner G. C., Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxidants and Redox Signaling 2005 7 11-12 1476 1482 2-s2.0-28844434974 10.1089/ars.2005.7.1476 (Pubitemid 41767982)
115. Kassab A., Piwowar A., Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes. Biochimie 2012 94 9 1837 1848 2-s2.0-84864282827 10.1016/j.biochi.2012.01.020
116. Yasunari K., Kohno M., Kano H., Minami M., Yoshikawa J., Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary artery smooth muscle cells induced by high glucose. Hypertension 2000 35 5 1092 1098 2-s2.0-0034074092 (Pubitemid 30327263)
117. Ng T. F., Lee F. K., Song Z. T., Calcutt N. A., Lee A. Y. W., Chung S. S. M., Chung S. K., Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes 1998 47 961 966 2-s2.0-0031822988 (Pubitemid 28255672)
118. Lee A. Y. W., Chung S. S. M., Contributions of polyol pathway to oxidative stress in diabetic cataract. The FASEB Journal 1999 13 1 23 30 2-s2.0-0032958288 (Pubitemid 29038271)
119. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615 (Pubitemid 40770750)
120. Yabe-Nishimura C., Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacological Reviews 1998 50 1 21 33 2-s2.0-0031920049 (Pubitemid 28158840)
121. Dunlop M., Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney International, Supplement 2000 58 77 S3 S12 2-s2.0-0033857113
122. Sena L. A., Chandel N. S., Physiological roles of mitochondrial reactive oxygen species. Molecular Cell 2012 48 2 158 166 2-s2.0-84868007565 10.1016/j.molcel.2012.09.025
123. Li Q., Hwang Y. C., Ananthakrishnan R., Oates P. J., Guberski D., Ravichandran R., Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts. Cardiovascular Diabetology 2008 7, article 33 2-s2.0-56649108242 10.1186/1475-2840-7-33
124. Gabbay K. H., The sorbitol pathway and the complications of diabetes. The New England Journal of Medicine 1973 288 16 831 836 2-s2.0-0015929739
125. Kador P. F., Kinoshita J. H., Role of aldose reductase in the development of diabetes-associated complications. The American Journal of Medicine A 1985 79 5 8 12 2-s2.0-0022374267 (Pubitemid 16213222)
126. Yan L.-J., Christians E. S., Liu L., Xiao X., Sohal R. S., Benjamin I. J., Mouse heat shock transcription factor 1 deficiency alters cardiac redox homeostasis and increases mitochondrial oxidative damage. The EMBO Journal 2002 21 19 5164 5172 2-s2.0-0036790590 10.1093/emboj/cdf528
127. Ohmura C., Watada H., Azuma K., Shimizu T., Kanazawa A., Ikeda F., Yoshihara T., Fujitani Y., Hirose T., Tanaka Y., Kawamori R., Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes. Endocrine Journal 2009 56 1 149 156 2-s2.0-62549114064 10.1507/endocrj.K08E-237
128. Yeung C.-M., Lo A. C. Y., Cheung A. K. H., Chung S. S. M., Wong D., Chung S. K., More severe type 2 diabetes-associated ischemic stroke injury is alleviated in aldose reductase-deficient mice. Journal of Neuroscience Research 2010 88 9 2026 2034 2-s2.0-77953481998 10.1002/jnr.22349
129. Tang W. H., Martin K. A., Hwa J., Aldose reductase, oxidative stress, and diabetic mellitus. Frontiers in Pharmacology 2012 3, article 87 2-s2.0-84863847452 10.3389/fphar.2012.00087
130. Tang W. H., Wu S., Wong T. M., Chung S. K., Chung S. S. M., Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart. Free Radical Biology and Medicine 2008 45 5 602 610 2-s2.0-48449094505 10.1016/j.freeradbiomed.2008.05.003
131. Hwang Y. C., Bakr S., Ellery C. A., Oates P. J., Ramasamy R., Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium. The FASEB Journal 2003 17 15 2331 2333 2-s2.0-0642272495 10.1096/fj.03-0128fje (Pubitemid 39561483)
132. Cameron N. E., Cotter M. A., The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes/Metabolism Reviews 1994 10 3 189 224 2-s2.0-0028040725 (Pubitemid 24306134)
133. Issad T., Masson E., Pagesy P., O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes and Metabolism 2010 36 6 423 435 2-s2.0-78649990012 10.1016/j.diabet.2010.09.001
134. Ma J., Hart G. W., Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Review of Proteomics 2013 10 365 380
135. Fardini Y., Masson E., Boudah O., Ben Jouira R., Cosson C., Pierre-Eugene C., Kuo M. S., Issad T., O-GlcNAcylation of FoxO1 in pancreatic beta cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism. The FASEB Journal 2014 28 1010 1021
136. Gupta Rajapakse A., Ming X.-F., Carvas J. M., Yang Z., O-linked β -N-acetylglucosamine during hyperglycemia exerts both anti-inflammatory and pro-oxidative properties in the endothelial system. Oxidative Medicine and Cellular Longevity 2009 2 3 172 175 2-s2.0-77953442462
137. Goldberg H., Whiteside C., George Fantus I., O-linked β -N-acetylglucosa mine supports p38 MAPK activation by high glucose in glomerular mesangial cells. The American Journal of Physiology: Endocrinology and Metabolism 2011 301 4 E713 E726 2-s2.0-80053280712 10.1152/ajpendo.00108.2011
138. Lima V. V., Spitler K., Choi H., Webb R. C., Tostes R. C., O-glcnacylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? Clinical Science 2012 123 8 473 486 2-s2.0-84864018110 10.1042/CS20110638
139. McLarty J. L., Marsh S. A., Chatham J. C., Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart. Life Sciences 2013 92 11 621 627 2-s2.0-84875221904 10.1016/j.lfs.2012.08.006
140. Gurel Z., Sieg K. M., Shallow K. D., Sorenson C. M., Sheibani N., Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy. Molecular Vision 2013 19 1047 1059 2-s2.0-84878211324
141. Schleicher E. D., Weigert C., Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney International, Supplement 2000 58 77 S13 S18 2-s2.0-0033852661
142. Semba R. D., Huang H., Lutty G. A., Van Eyk J. E., Hart G. W., The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy. Proteomics: Clinical Applications 2014 8 218 231
143. Feng B., Ruiz M. A., Chakrabarti S., Oxidative-stress-induced epigenetic changes in chronic diabetic complications. Canadian Journal of Physiology and Pharmacology 2013 91 3 213 220 2-s2.0-84875481512 10.1139/cjpp-2012-0251
144. Xia L., Wang H., Munk S., Frecker H., Goldberg H. J., Fantus I. G., Whiteside C. I., Reactive oxygen species, PKC- 1, and PKC- ζ mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells. The American Journal of Physiology: Endocrinology and Metabolism 2007 293 5 E1280 E1288 2-s2.0-36148929033 10.1152/ajpendo.00223.2007 (Pubitemid 350106595)
145. Sasaki S., Inoguchi T., The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes and Metabolism Journal 2012 36 4 255 261 2-s2.0-84869006545 10.4093/dmj.2012.36.4.255
146. Xia L., Wang H., Munk S., Kwan J., Goldberg H. J., Fantus I. G., Whiteside C. I., High glucose activates PKC- ζ and NADPH oxidase through autocrine TGF- β 1 signaling in mesangial cells. The American Journal of Physiology: Renal Physiology 2008 295 6 F1705 F1714 2-s2.0-57349111176 10.1152/ajprenal.00043.2008
147. Teshima Y., Takahashi N., Nishio S., Saito S., Kondo H., Fukui A., Aoki K., Yufu K., Nakagawa M., Saikawa T., Production of reactive oxygen species in the diabetic heart: roles of mitochondria and NADPH oxidase. Circulation Journal 2014 78 300 306
148. Fontayne A., Dang P. M.-C., Gougerot-Pocidalo M.-A., El Benna J., Phosphorylation of p47phox sites by PKC β II, δ and ζ: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 2002 41 24 7743 7750 2-s2.0-0037129803 10.1021/bi011953s (Pubitemid 34627801)
149. Bey E. A., Xu B., Bhattacharjee A., Oldfield C. M., Zhao X., Li Q., Subbulakshmi V., Feldman G. M., Wientjes F. B., Cathcart M. K., Protein kinase C δ is required for p47phox phosphorylation and translocation in activated human monocytes. Journal of Immunology 2004 173 9 5730 5738 2-s2.0-6344269853 (Pubitemid 39392162)
150. Naruse K., Rask-Madsen C., Takahara N., Ha S.-W., Suzuma K., Way K. J., Jacobs J. R. C., Clermont A. C., Ueki K., Ohshiro Y., Zhang J., Goldfine A. B., King G. L., Activation of vascular protein kinase C-beta; inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes 2006 55 3 691 698 2-s2.0-33644781862 (Pubitemid 43343225)
151. Mellor K. M., Brimble M. A., Delbridge L. M., Glucose as an agent of post-translational modification in diabetes: new cardiac epigenetic insights. Life sciences 2014 10.1016/j.lfs.2014.03.020
152. Lovestone S., Smith U., Advanced glycation end products, dementia, and diabetes. Proceedings of the National Academy of Sciences of the United States of America 2014 111 4743 4744
153. Queisser M. A., Yao D., Geisler S., Hammes H.-P., Lochnit G., Schleicher E. D., Brownlee M., Preissner K. T., Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 2010 59 3 670 678 2-s2.0-77950362951 10.2337/db08-1565
154. Thornalley P. J., Langborg A., Minhas H. S., Formation of glyoxal, methylglyoxal and 8-deoxyglucosone in the glycation of proteins by glucose. Biochemical Journal 1999 344 1 109 116 2-s2.0-0033571012 10.1042/0264-6021: 3440109
155. Koga M., Murai J., Morita S., Saito H., Kasayama S., Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus. Journal of Diabetes and its Complications 2013 27 3 211 213 2-s2.0-84876909036 10.1016/j.jdiacomp.2012.12.001
156. Gholap N. N., Davies M. J., Mostafa S. A., Khunti K., Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria. British Journal of General Practice 2013 63 607 e165 e167 2-s2.0-84873102490 10.3399/bjgp13X663244
157. Wells-Knecht K. J., Brinkmann E., Wells-Knecht M. C., Litchfield J. E., Ahmed M. U., Reddy S., Zyzak D. V., Thorpe S. R., Baynes J. W., New biomarkers of Maillard reaction damage to proteins. Nephrology Dialysis Transplantation 1996 11 5 41 47 2-s2.0-0030483803 (Pubitemid 27062910)
158. Wells-Knecht K. J., Zyzak D. V., Litchfield J. E., Thorpe S. R., Baynes J. W., Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995 34 11 3702 3709 2-s2.0-0028951461 10.1021/bi00011a027
159. Muñoz A., Costa M., Nutritionally mediated oxidative stress and inflammation. Oxidative Medicine and Cellular Longevity 2013 2013 11 2-s2.0-84880311913 10.1155/2013/610950 610950
160. Hayden M. R., Tyagi S. C., Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. Journal of the Pancreas 2002 3 4 86 108 2-s2.0-0036632466 (Pubitemid 38963816)
161. Vlassara H., Striker G. E., Advanced glycation endproducts in diabetes and diabetic complications. Endocrinology and Metabolism Clinics of North America 2013 42 697 719
162. Mira M. L., Martinho F., Azevedo M. S., Manso C. F., Oxidative inhibition of red blood cell ATPases by glyceraldehyde. Biochimica et Biophysica Acta: Bioenergetics 1991 1060 3 257 261 2-s2.0-0025952639
163. Wolff S. P., Dean R. T., Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochemical Journal 1987 245 1 243 250 2-s2.0-0023259759 (Pubitemid 17089839)
164. Eiselein L., Schwartz H. J., Rutledge J. C., The challenge of type 1 diabetes mellitus. ILAR Journal 2004 45 3 231 236 2-s2.0-21644456271
165. Bocci V., Zanardi I., Huijberts M. S., Travagli V., An integrated medical treatment for type-2 diabetes. Diabetes and Metabolic Syndrome 2014 8 57 61
166. Ye J., Mechanisms of insulin resistance in obesity. Frontiers of Medicine in China 2013 7 1 14 24 2-s2.0-84874806070 10.1007/s11684-013-0262-6
167. Yang X., Feng L., Li C., Li Y., Tranilast alleviates endothelial dysfunctions and insulin resistance via preserving glutathione peroxidase 1 in rats fed a high-fat emulsion. Journal of Pharmacological Sciences 2014 124 18 30
168. Robertson R. P., Zhang H.-J., Pyzdrowski K. L., Walseth T. F., Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. Journal of Clinical Investigation 1992 90 2 320 325 2-s2.0-0026757632
169. Karunakaran U., Park K.-G., A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense. Diabetes and Metabolism Journal 2013 37 2 106 112 2-s2.0-84877816996 10.4093/dmj.2013.37. 2.106
170. Katsuki A., Sumida Y., Urakawa H., Gabazza E. C., Murashima S., Nakatani K., Yano Y., Adachi Y., Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diabetes Care 2004 27 2 631 632 2-s2.0-0842333066 10.2337/diacare.27.2.631 (Pubitemid 38174109)
171. Wittmann I., Nagy J., Ceriello A., Pirisi M., Are insulin resistance and atherosclerosis the consequences of oxidative stress? Diabetologia 1996 39 8 1002 1003 2-s2.0-0029903001 10.1007/s001250050546 (Pubitemid 26249124)
172. Paolisso G., D'Amore A., Volpe C., Balbi V., Saccomanno F., Galzerano D., Giugliano D., Varricchio M., D'Onofrio F., Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism: Clinical and Experimental 1994 43 11 1426 1429 2-s2.0-0028125254 10.1016/0026-0495(94)90039-6 (Pubitemid 24353109)
173. Urakawa H., Katsuki A., Sumida Y., Gabazza E. C., Murashima S., Morioka K., Maruyama N., Kitagawa N., Tanaka T., Hori Y., Nakatani K., Yano Y., Adachi Y., Oxidative stress ts associated with adiposity and insulin resistance in men. Journal of Clinical Endocrinology and Metabolism 2003 88 10 4673 4676 2-s2.0-10744222995 10.1210/jc.2003-030202 (Pubitemid 37357510)
174. Tanaka Y., Gleason C. E., Tran P. O. T., Harmon J. S., Robertson R. P., Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proceedings of the National Academy of Sciences of the United States of America 1999 96 19 10857 10862 2-s2.0-0032863183 10.1073/pnas.96.19. 10857 (Pubitemid 29442234)
175. Robertson R. P., Tanaka Y., Takahashi H., Tran P. O. T., Harmon J. S., Prevention of oxidative stress by adenoviral overexpression of glutathione-related enzymes in pancreatic islets. Annals of the New York Academy of Sciences 2005 1043 513 520 2-s2.0-23744490763 10.1196/annals.1333.058 (Pubitemid 41123940)
176. Matsuoka T.-A., Kajimoto Y., Watada H., Kaneto H., Kishimoto M., Umayahara Y., Fujitani Y., Kamada T., Kawamori R., Yamasaki Y., Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. Journal of Clinical Investigation 1997 99 1 144 150 2-s2.0-0031020374 (Pubitemid 27058305)
177. Butler A. E., Janson J., Bonner-Weir S., Ritzel R., Rizza R. A., Butler P. C., β -cell deficit and increased β -cell apoptosis in humans with type 2 diabetes. Diabetes 2003 52 1 102 110 2-s2.0-0037219411 10.2337/diabetes.52.1.102 (Pubitemid 36042113)
178. Pennathur S., Wagner J. D., Leeuwenburgh C., Litwak K. N., Heinecke J. W., A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. Journal of Clinical Investigation 2001 107 7 853 860 2-s2.0-0035057229 (Pubitemid 32274038)
179. Rindler P. M., Crewe C. L., Fernandes J., Kinter M., Szweda L. I., Redox regulation of insulin sensitivity due to enhanced fatty acid utilization in the mitochondria. The American Journal of Physiology: Heart and Circulatory Physiology 2013 305 5 H634 H643 2-s2.0-84883374607 10.1152/ajpheart.00799.2012
180. Henriksen E. J., Diamond-Stanic M. K., Marchionne E. M., Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radical Biology and Medicine 2011 51 5 993 999 2-s2.0-80051669138 10.1016/j. freeradbiomed.2010.12.005
181. Katakam P. V. G., Snipes J. A., Steed M. M., Busija D. W., Insulin-induced generation of reactive oxygen species and uncoupling of nitric oxide synthase underlie the cerebrovascular insulin resistance in obese rats. Journal of Cerebral Blood Flow and Metabolism 2012 32 5 792 804 2-s2.0-84860490592 10.1038/jcbfm.2011.181
182. Fisher-Wellman K. H., Neufer P. D., Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends in Endocrinology and Metabolism 2012 23 3 142 153 2-s2.0-84857687489 10.1016/j.tem.2011.12.008
183. Lemasters J. J., Nieminen A.-L., Mitochondrial oxygen radical formation during reductive and oxidative stress to intact hepatocytes. Bioscience Reports 1997 17 3 281 291 2-s2.0-0030702781 10.1023/A:1027332611839 (Pubitemid 27466752)
184. Cernea S., Dobreanu M., Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochemical Medicine 2013 23 266 280
185. Roseman H. M., Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management. Journal of Managed Care Pharmacy 2005 11 6, supplement S3 S11 2-s2.0-84875182508
186. Johnson E. L., Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications. Advances in Experimental Medicine and Biology 2012 771 139 154 2-s2.0-84874540697
187. Tiganis T., Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends in Pharmacological Sciences 2011 32 2 82 89 2-s2.0-79651474666 10.1016/j.tips.2010.11.006
188. Rains J. L., Jain S. K., Oxidative stress, insulin signaling, and diabetes. Free Radical Biology and Medicine 2011 50 5 567 575 2-s2.0-79551470306 10.1016/j.freeradbiomed.2010.12.006
189. Piconi L., Quagliaro L., Ceriello A., Oxidative stress in diabetes. Clinical Chemistry and Laboratory Medicine 2003 41 9 1144 1149 2-s2.0-0142061586 10.1515/CCLM.2003.177 (Pubitemid 37265692)
190. Ceriello A., New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003 26 5 1589 1596 2-s2.0-0042093769 10.2337/diacare.26.5.1589 (Pubitemid 36929196)
191. Yan L.-J., Yang S.-H., Shu H., Prokai L., Forster M. J., Histochemial staining and qualification of dihydrolipoamide dehydrogenase diaphorase activity using blue native PAGE. Electrophoresis 2007 28 7 1036 1045 2-s2.0-34247114586 10.1002/elps.200600574 (Pubitemid 46592899)